Peter Evan Harwin, Director: Dianthus Therapeutics DNTH Buy · Filed 23/10/03

Trade details

Type: Insider buy
Amount: $336,252.1
Shares · price: 24,670 sh · $13.63 a share
Held after: 1,928,503 sh
Stock: Dianthus Therapeutics DNTH
Person: Peter Evan HarwinDirector
Trade date: 23/09/29
Filed: 23/10/03
Days to filing: 4 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +1.3%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/30~23/10/29

Peter Evan Harwin's recent trades

Peter Evan HarwinDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Peter Evan HarwinDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
Peter Evan HarwinDirector
SellApogee Therapeutics
Sell
Apogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
Peter Evan HarwinDirector
BuyCrescent Biopharma
Buy
Crescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
Peter Evan HarwinDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$6M
316,219 sh
$6M
Filed 25/10/09
Traded 25/10/07